FUNDC2
FUN14 domain-containing protein 2
Also known as: DC44, FUND2_HUMAN, HCBP6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BWH2
- Gene
- FUNDC2
- Ensembl
- ENSG00000165775
- Chromosome
- X
- Canonical length
- 189 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables phosphatidylinositol-3,4,5-trisphosphate binding activity. Involved in intracellular triglyceride homeostasis. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
189 residues, UniProt reviewed canonical sequence.
>Q9BWH2|FUNDC2
1 METSAPRAGS QVVATTARHS AAYRADPLRV SSRDKLTEMA ASSQGNFEGN FESLDLAEFA
61 KKQPWWRKLF GQESGPSAEK YSVATQLFIG GVTGWCTGFI FQKVGKLAAT AVGGGFFLLQ
121 LANHTGYIKV DWQRVEKDMK KAKEQLKIRK SNQIPTEVRS KAEEVVSFVK KNVLVTGGFF
181 GGFLLGMASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FUNDC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- tongue: 18 nTPM
- skeletal muscle: 17 nTPM
- heart muscle: 9.7 nTPM
- pancreas: 7.3 nTPM
- ovary: 5.7 nTPM
- choroid plexus: 5.3 nTPM
Single-cell type
- late spermatids: 2,447 nCPM
- early spermatids: 345 nCPM
- pancreatic acinar cells: 281 nCPM
- parietal cells: 210 nCPM
- decidual stromal cells: 161 nCPM
- mast cells: 131 nCPM
Immune cell
- total PBMC: 3.3 nTPM
- non-classical monocyte: 2.9 nTPM
- myeloid DC: 2.7 nTPM
- naive CD8 T-cell: 2.6 nTPM
- T-reg: 2.6 nTPM
- gdT-cell: 2.5 nTPM
Brain region
- cerebellum: 6 nTPM
- pons: 5.3 nTPM
- medulla oblongata: 5.1 nTPM
- thalamus: 5.1 nTPM
- choroid plexus: 4.9 nTPM
- spinal cord: 4.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 5-trisphosphate binding
- phosphatidylinositol-3
- 4
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FUNDC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FUNDC2 as an antibody target. Whether an autoantibody or antibody against FUNDC2 could matter depends on whether native FUNDC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FUNDC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FUNDC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...